(Q41736712)

8 October 2017

The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67. (English)

1 reference

8 October 2017

0 references

Goodson WH 3rd

1

1 reference

8 October 2017

Moore DH 2nd

2

1 reference

8 October 2017

Ljung BM

3

1 reference

8 October 2017

Chew K

4

1 reference

8 October 2017

Mayall B

5

1 reference

8 October 2017

Smith HS

6

1 reference

8 October 2017

Waldman FM

7

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Breast Cancer Research and Treatment

8 October 2017

1 reference

8 October 2017

59

1 reference

8 October 2017

2

1 reference

8 October 2017

113-123

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006344010050

8 October 2017

0 references

cites work

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

In vivo measurement of breast cancer growth rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

Tumor labeling indices of primary breast cancers and their regional lymph node metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

Prognostic implications of the bromodeoxyuridine labeling index of human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

Estimation of growth fraction in situ in human bladder cancer with bromodeoxyuridine labelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

Monoclonal antibody Ki-67: its use in histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

The functional relationship between in vivo bromodeoxyuridine labeling index and Ki-67 proliferation index in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

S-phase fraction and nuclear size in long term prognosis of patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

Cytometric and histopathologic features of tumors detected in a randomized mammography screening program: correlation and relative prognostic influence

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Growth rate, kinetics of tumor cell proliferation and long-term outcome in human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Influences on measurement of cellular proliferation by histology and flow cytometry in mammary carcinomas labeled in vivo with bromodeoxyuridine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Cell kinetics in vivo of human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Evidence for quiescent S- and G2-phase cells in human colorectal carcinomas: a flow cytometric study with the Ki-67 antibody

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Cell kinetics in human breast cancer: comparison between the prognostic value of the cytofluorimetric S-phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunocytochemistry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Comparison of cell growth in different parts of breast cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Sentinel lymphadenectomy in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006344010050

7 January 2021

Identifiers

DOI

10.1023/A:1006344010050

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4vcaazxe2zbo3ehloyzgasrnhu

30 July 2022

mapped directly with Wikidata item

Dimensions Publication ID

1046084352

0 references

Fatcat ID

release_4vcaazxe2zbo3ehloyzgasrnhu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4vcaazxe2zbo3ehloyzgasrnhu

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/4vcaazxe2zbo3ehloyzgasrnhu

30 July 2022